Drug Type Small molecule drug |
Synonyms Pefcalcitol (JAN/USAN/INN), CLS 008, CLS-008 + [4] |
Target |
Mechanism VDR agonists(Vitamin D receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedNDA/BLA |
First Approval Date- |
Regulation- |
Molecular FormulaC26H34F5NO4 |
InChIKeySVCSMAZYWOQCBW-NVJMFHFGSA-N |
CAS Registry381212-03-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Plaque psoriasis | NDA/BLA | US | 08 Jun 2016 | |
Keratoderma, Palmoplantar | Phase 3 | JP | 20 May 2015 | |
Psoriasis | Phase 3 | AT | 01 Oct 2013 | |
Psoriasis | Phase 3 | BG | 01 Oct 2013 | |
Psoriasis | Phase 3 | DE | 01 Oct 2013 | |
Psoriasis | Phase 3 | HU | 01 Oct 2013 | |
Psoriasis | Phase 3 | LT | 01 Oct 2013 | |
Psoriasis | Phase 3 | PL | 01 Oct 2013 | |
Warts | Phase 2 | JP | 10 Apr 2018 |